Johannes Jacob Pieter Kastelein, Chief Scientific Officer at NewAmsterdam Pharma Co N.V. (NAMS), sold 201,673 shares at $21.50 ($4.3M) on 2024-03-26, disclosed to the SEC on 2024-03-27.
Open-market sale of $4.3M NAMS by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.50 | 190,476 | $4.1M | 94.2% |
| 2 | $22.72 | 11,197 | $254K | 5.8% |
| Total | $21.57 avg | 201,673 | $4.3M | 100% |
| Filing → |
| NAMS | SELL | 2026-02-24 | $1.6M | — | Filing → |
| NAMS | SELL | 2026-01-07 | $200K | — | Filing → |
| NAMS | SELL | 2025-08-25 | $3.7M | — | Filing → |